Fairmount Funds Management LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-17 9:00 pm Purchase | 2024-09-13 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 15,556,685 17.950% | 1,600,000 (+11.46%) | Filing |
| 2024-04-01 6:38 pm Unchanged | 2024-03-28 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 13,956,685 18.640% | 0 (Unchanged) | Filing |
| 2024-01-24 5:12 pm Purchase | 2024-01-22 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 13,956,685 19.430% | 1,192,292 (+9.34%) | Filing |
| 2023-11-03 4:30 pm Purchase | 2023-10-30 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 12,764,393 19.990% | 3,571,579 (+38.85%) | Filing |
| 2022-08-19 4:34 pm Purchase | 2022-08-17 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 9,192,814 19.990% | 5,732,463 (+165.66%) | Filing |
| 2021-09-23 4:31 pm Purchase | 2021-09-21 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 3,460,351 19.990% | 3,460,351 (New Position) | Filing |